Bronchiolitis obliterans following haematopoietic stem cell transplantation
نویسندگان
چکیده
منابع مشابه
Bronchiolitis obliterans following haematopoietic stem cell transplantation.
The aim of the present article is to review the available clinical data on bronchiolitis obliterans following haematopoietic stem cell transplantation (HSCT). The data sources used were the Medline database and references from the identified articles related to bronchiolitis obliterans, noninfectious pulmonary complications and HSCT. HSCT is an important treatment for a variety of malignant and...
متن کاملRituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation.
diagnosis and treatment of tuberculosis. BMC Public Health 2008; 8: 15. 8 Borgdorff MW, van der Werf MJ, de Haas PEW, et al. Tuberculosis elimination in the Netherlands. Emerg Infect Dis 2005; 11: 597–602. 9 Brinkmann B, Du Chesne A, Vennemann B. A survey of autopsy rates in Germany. Dtsch Med Wochenschr 2002; 127: 791–795. 10 Lefebvre N, Falzon D. Risk factors for death among tuberculosis case...
متن کاملCalcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.
Bronchiolitis obliterans is a complication after allogeneic haematopoietic stem cell transplantation (HSCT). Management of bronchiolitis obliterans comprises intensive immunosuppression, but treatment response is poor. We investigated the effect of cyclosporine A (CsA), tacrolimus (FK506), methylprednisolone (mPRED), mycophenolate mofetil (MMF) and everolimus on the proliferation of primary lun...
متن کاملBronchiolitis obliterans following lung transplantation.
Bronchiolitis obliterans syndrome (BOS) is the main and late chronic complication after lung transplantation. It remains a major impediment to long-term outcome. Unfortunately, the survival rate of lung transplant recipients lags behind that of other organ transplant recipients, and BOS accounts for more than 30% of all mortality after the third year following lung transplantation. Most recent ...
متن کاملbronchiolitis obliterans following hematopoietic stem cell transplantation: risk factors and diagnostic methods
introduction: bronchiolitis obliterans (bo) is one of the most important pulmonary complications of hematopoietic stem cell transplantation (hsct). we decided to evaluate the prevalence and risk factors of bo in hsct patients in the shariati hospital oncology research center. materials and methods: forty two patients, who had had hsct for at least 6 months ago, completed the study. the diagnosi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Respiratory Journal
سال: 2007
ISSN: 0903-1936,1399-3003
DOI: 10.1183/09031936.00052806